ATC
XBI icon

Argent Trust Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Argent Trust Co’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Hold
8,497
– – 0.04% 334
2025
Q4 		$1.04M Buy
8,497
+1,795
+27% +$206K 0.04% 330
2025
Q3 		$672K Sell
6,702
-150
-2% -$13.5K 0.02% 400
2025
Q2 		$568K Sell
6,852
-3,230
-32% -$258K 0.02% 422
2025
Q1 		$818K Sell
10,082
-146
-1% -$13.1K 0.03% 341
2024
Q4 		$921K Sell
10,228
-575
-5% -$55.7K 0.04% 308
2024
Q3 		$1.07M Buy
10,803
+3,562
+49% +$350K 0.04% 306
2024
Q2 		$671K Sell
7,241
-400
-5% -$35.9K 0.03% 369
2024
Q1 		$725K Sell
7,641
-38
-0.5% -$3.53K 0.03% 359
2023
Q4 		$686K Sell
7,679
-8,528
-53% -$633K 0.03% 353
2023
Q3 		$1.18M Buy
16,207
+9,675
+148% +$773K 0.06% 248
2023
Q2 		$543K Sell
6,532
-66
-1% -$5.52K 0.03% 385
2023
Q1 		$503K Sell
6,598
-40
-0.6% -$3.32K 0.03% 348
2022
Q4 		$551K Hold
6,638
– – 0.04% 330
2022
Q3 		$527K Sell
6,638
-556
-8% -$46.9K 0.04% 325
2022
Q2 		$534K Sell
7,194
-90
-1% -$6.76K 0.04% 331
2022
Q1 		$655K Sell
7,284
-15
-0.2% -$1.39K 0.04% 315
2021
Q4 		$817K Sell
7,299
-1,200
-14% -$145K 0.05% 288
2021
Q3 		$1.07M Hold
8,499
– – 0.07% 233
2021
Q2 		$1.15M Sell
8,499
-27
-0.3% -$3.55K 0.08% 216
2021
Q1 		$1.16M Buy
8,526
+32
+0.4% +$4.79K 0.08% 216
2020
Q4 		$1.2M Sell
8,494
-149
-2% -$19.1K 0.09% 193
2020
Q3 		$963K Sell
8,643
-33
-0.4% -$3.7K 0.08% 201
2020
Q2 		$971K Hold
8,676
– – 0.09% 198
2020
Q1 		$672K Sell
8,676
-979
-10% -$86.7K 0.08% 221
2019
Q4 		$918K Hold
9,655
– – 0.08% 217
2019
Q3 		$736K Sell
9,655
-9
-0.1% -$748 0.07% 242
2019
Q2 		$848K Hold
9,664
– – 0.09% 213
2019
Q1 		$875K Hold
9,664
– – 0.09% 202
2018
Q4 		$693K Buy
9,664
+30
+0.3% +$2.42K 0.08% 217
2018
Q3 		$908K Sell
9,634
-6
-0.1% -$582 0.1% 179
2018
Q2 		$917K Buy
+9,640
New +$886K 0.11% 181

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Argent Trust Co's XBI Position: Q1 2026 in Review

Argent Trust Co held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 8,497 shares worth $1.09M. The position accounts for 0.04% of the portfolio, ranked #334.

Argent Trust Co first reported a position in XBI in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.2M in Q4 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Argent Trust Co held 8,497 shares of State Street SPDR S&P Biotech ETF worth $1.09M as of Q1 2026.
  • Argent Trust Co left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
  • State Street SPDR S&P Biotech ETF made up 0.04% of Argent Trust Co's portfolio in Q1 2026, its #334 holding.
  • Argent Trust Co first reported a position in State Street SPDR S&P Biotech ETF in Q2 2018 and has held it in 32 quarters since.
  • Argent Trust Co's State Street SPDR S&P Biotech ETF position peaked at $1.2M in Q4 2020.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.